StockData
LFTD Partners Inc. logo

LFTD Partners Inc. (LIFD) stock

LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

LFTD Partners gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

LFTD Partners's gross profit for the twelve months ending Mar 31, 2026 was $8.70M. For fiscal 2025 it was $12.62M, down 1.1% from the year before. The highest annual figure on record is $20.99M in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.62M-1.1%
FY2024Dec 31, 2024$12.75M-35.3%
FY2023Dec 31, 2023$19.70M-6.1%
FY2022Dec 31, 2022$20.99M+31.7%
FY2021Dec 31, 2021$15.94M+723.0%
FY2020Dec 31, 2020$1.94M–
FY2019Dec 31, 2019$0–
FY2012Dec 31, 2012-$26.74K-110.0%
FY2011Dec 31, 2011$267.99K-88.6%
FY2010Dec 31, 2010$2.34M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$1.71M-176.9%
Q4 FY2025Dec 31, 2025$3.00M+45.7%
Q3 FY2025Sep 30, 2025$4.16M+10.6%
Q2 FY2025Jun 30, 2025$3.25M-18.8%
Q1 FY2025Mar 31, 2025$2.22M-49.9%
Q4 FY2024Dec 31, 2024$2.06M-63.5%
Q3 FY2024Sep 30, 2024$3.76M-33.5%
Q4 FY2023Dec 31, 2023$4.00M-3.2%
Q3 FY2023Sep 30, 2023$4.42M+443.4%
Q2 FY2023Jun 30, 2023$5.64M-30.1%
Q1 FY2023Mar 31, 2023$5.65M-29.3%
Q4 FY2022Dec 31, 2022$4.13M-36.8%
Q3 FY2022Sep 30, 2022$813.74K-80.2%
Q2 FY2022Jun 30, 2022$8.06M+120.3%
Q1 FY2022Mar 31, 2022$7.98M+385.2%
Q4 FY2021Dec 31, 2021$6.54M+639.6%
Q3 FY2021Sep 30, 2021$4.10M+549.8%
Q2 FY2021Jun 30, 2021$3.66M+1364.4%
Q1 FY2021Mar 31, 2021$1.65M+855.1%
Q4 FY2020Dec 31, 2020$883.57K–
Q3 FY2020Sep 30, 2020$631.11K–
Q2 FY2020Jun 30, 2020$249.90K–
Q1 FY2020Mar 31, 2020$172.32K–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0–

More LFTD Partners figures

See a number that looks wrong?